Guido Torzilli
Overview
Explore the profile of Guido Torzilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
319
Citations
4652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serenari M, Berti D, Rivera B, Newhook T, Kristjanpoller W, Ruzzenente A, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40050485
Background: Gallbladder cancer (GBC) has a poor prognosis, particularly in advanced stages, with surgery often offering limited survival benefit. This study aimed to identify risk factors for futile surgery (FS),...
2.
Milana F, Procopio F, Calafiore E, Famularo S, Costa G, Galvanin J, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 40019600
Background: R0 resection is the standard for mass-forming cholangiocarcinoma (MFCCC). R1vasc resection (tumor-vessel detachment) yielded results comparable to R0 and superior to parenchymal-tumor exposure (R1par) for hepatocellular carcinoma and colorectal...
3.
Papakonstantinou M, Fantakis A, Torzilli G, Donadon M, Chatzikomnitsa P, Giakoustidis D, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004679
Colorectal cancer is the second most common type of cancer and a leading cause of cancer-related deaths worldwide. Approximately 15% of the patients with colorectal cancer will already have liver...
4.
Cassese G, C Giglio M, Vitale A, Lauterio A, Serenari M, Cipriani F, et al.
HPB (Oxford)
. 2025 Feb;
PMID: 39956728
Background: Recent papers report significant survival gain after liver resection in BCLC-B and -C HCC patients. The results of minimally invasive liver surgery (MILS) in such patients have not been...
5.
Romano S, Lanza E, Ammirabile A, Ferrillo G, Tenuta E, Poretti D, et al.
Abdom Radiol (NY)
. 2025 Feb;
PMID: 39909942
Purpose: This retrospective study aimed to confirm the safety and long-term efficacy of a single-session combined treatment approach with transcatheter arterial embolization (TAE) and microwave ablation (MWA) for inoperable small-to...
6.
Procopio F, Galvanin J, Mauri G, Famularo S, Pedicini V, Milana F, et al.
Surgery
. 2025 Jan;
180():109138.
PMID: 39854785
Background: Communicating vessels among hepatic veins in patients with tumors invading/compressing hepatic veins at their caval confluence facilitate new surgical solutions. Although their recognition by intraoperative ultrasound has been described,...
7.
Torres O, Torzilli G, Enne M, Goncalves R, De Santibanes E, Pawlik T, et al.
Arq Bras Cir Dig
. 2025 Jan;
37():e1859.
PMID: 39841764
The development of surgical techniques, chemotherapy, biological agents, and multidisciplinary approaches have made patients with unresectable colorectal liver metastases eligible for surgery. Many strategies have been developed to allow patients...
8.
Famularo S, Milana F, Ardito F, Cipriani F, Vitale A, Lauterio A, et al.
HPB (Oxford)
. 2025 Jan;
PMID: 39800599
Background: Minimal access liver surgery (MALS) is considered superior to open liver resection (OLR) in reducing the perioperative risk in patients affected by hepatocellular carcinoma (HCC). No national-level comparisons exist...
9.
Wu C, Targher G, Byrne C, Mao Y, Cheung T, Yilmaz Y, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39749919
Introduction: The global burden of metabolic diseases is increasing, but estimates of their impact on primary liver cancer are uncertain. We aimed to assess the global burden of primary liver...
10.
Ammirabile A, Cavinato L, Ferro C, Fiz F, Savino M, Russolillo N, et al.
Eur J Surg Oncol
. 2024 Dec;
51(3):109557.
PMID: 39729863
Introduction: The standard treatment of colorectal liver metastases (CRLM) is surgery with perioperative chemotherapy. A tumor response to systemic therapy confirmed at pathology examination is the strongest predictor of survival,...